Related Articles
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
Successful treatment of non‑small‑cell lung cancer with afatinib and a glucocorticoid following gefitinib‑ and erlotinib‑induced interstitial lung disease: A case report
Osimertinib (AZD9291) increases radio‑sensitivity in EGFR T790M non‑small cell lung cancer
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)